Head Office

Dendrite’s Managing Director publishes chapter on Clinical Registries in Laparoscopic Sleeve Gastrectomy book

LSG front cover Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.

10 January 2021

ABC Study registry to examine the outpatient treatment of COVID-19 Infections

ABC Study Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).

11 December 2020

Third UK bariatric report shows safety and effectiveness of surgery

Third National Bariatric Surgery Registry Report

Dendrite Clinical Systems, in conjunction with the British Obesity and Metabolic Surgery Society (BOMSS), have published the Third National Bariatric Surgery Registry Report that highlights the safety and effectiveness of bariatric and metabolic surgery in the UK. The report uses data from the National Bariatric Surgery Registry (NBSR), a decade long research collaboration between BOMSS and Dendrite Clinical Systems.

13 October 2020

FORECAST: Loss of a sense of smell reliable indicator of Covid-19

FORECAST_logo Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.

2 October 2020

New Zealand National Trauma Network and Dendrite launch new national trauma registry

Professor Ian Civil

The New Zealand National Trauma Network and Dendrite Clinical Systems have launched a new national trauma registry in the country. The ‘National Trauma Registry’ will collect and record data on approximately 2,400 patients who suffer major trauma in New Zealand every year. By recording and analysing data, trauma experts will be able to examine the quality of care provided and assess whether the system as a whole or individual regions, hospitals/centres are performing to an accepted standard and, if necessary, initiate quality improvements.

25 August 2020

Dendrite enters international ‘CoviDiab’ collaborative research initiative

International CoviDiab Registry Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.

24 June 2020

Sales, Finance & Administration		National Registries & Support
Phone	+44 1491 411 288	Phone	+44 1491 411 288
Fax	+44 1491 411 377	CTS	https://nscts.e-dendrite.com
E-mail	info@e-dendrite.com sales@e-dendrite.com finance@e-dendrite.com	E-mail	national-support@e-dendrite.com
International Support Telephone Numbers		Australia	+61 75 613 2073
		New Zealand	Auckland: +64 9887 0919
			Christchurch: +64 366 949 50

Dr Peter K. H. Walton

Managing Director
Dendrite Clinical Systems Ltd
The Hub, Station Road
Henley-on-Thames
Oxfordshire RG9 1AY
United Kingdom

Map